Citation: Ad. Tselepis et al., PAF-ACETYLHYDROLASE ACTIVITY IN FAMILIAL HYPERCHOLESTEROLEMIA, European journal of clinical investigation, 28(6), 1998, pp. 508-509
Authors:
ELISAF MS
SIAMOPOULOS KC
TSELEGARIDES TJ
BAIRAKTARI ET
GOUDEVENOS JA
TSELEPIS AD
TSOLAS OE
SIDERIS DA
Citation: Ms. Elisaf et al., LIPID ABNORMALITIES IN GREEK PATIENTS WITH CORONARY-ARTERY DISEASE, International journal of cardiology, 59(2), 1997, pp. 177-184
Authors:
TSELEPIS AD
BESIS S
ELISAF M
KARABINA SAP
LAPATSANIS PD
CHAPMAN MJ
SIAMOPOULOU A
Citation: Ad. Tselepis et al., REDUCED HDL LEVELS ARE A MAJOR FEATURE OF THE DYSLIPIDEMIA CHARACTERISTIC OF JUVENILE CHRONIC ARTHRITIS, Atherosclerosis, 134(1-2), 1997, pp. 45-45
Authors:
VINI MP
GOUDEVENOS J
LIAPIKOS T
TSOUKATOS D
MICHALIS L
SIDERIS D
TSELEPIS AD
Citation: Mp. Vini et al., SECRETION OF PAF-ACETYLHYDROLASE ACTIVITY DURING PLATELET-AGGREGATIONIN PATIENTS UNDERGOING CORONARY ANGIOPLASTY, Atherosclerosis, 134(1-2), 1997, pp. 186-187
Authors:
KARABINA SAP
ELISAF M
BAIRAKTARI E
TZALLAS C
SIAMOPOULOS KC
TSELEPIS AD
Citation: Sap. Karabina et al., INCREASED ACTIVITY OF PLATELET-ACTIVATING-FACTOR ACETYLHYDROLASE IN LOW-DENSITY-LIPOPROTEIN SUBFRACTIONS INDUCES ENHANCED LYSOPHOSPHATIDYLCHOLINE PRODUCTION DURING OXIDATION IN PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA, European journal of clinical investigation, 27(7), 1997, pp. 595-602
Authors:
KARABINA SAP
ELISAF MC
GOUDEVENOS J
SIAMOPOULOS KC
SIDERIS D
TSELEPIS AD
Citation: Sap. Karabina et al., PAF-ACETYLHYDROLASE ACTIVITY ON LP(A) BEFORE AND DURING CU2-INDUCED OXIDATIVE MODIFICATION IN-VITRO(), Atherosclerosis, 125(1), 1996, pp. 121-134
Authors:
TSELEPIS AD
ELISAF M
GOUDEVENOS J
TSELEGARIDIS T
BAIRAKTARI E
SIAMOPOULOS KC
SIDERIS D
Citation: Ad. Tselepis et al., LIPID PROFILE IN PATIENTS WITH MICROVASCULAR ANGINA, European journal of clinical investigation, 26(12), 1996, pp. 1150-1155
Citation: C. Dentan et al., PEFABLOC, 4-[2-AMINOETHYL]BENZENESULFONYL FLUORIDE, IS A NEW, POTENT NONTOXIC AND IRREVERSIBLE INHIBITOR OF PAF-DEGRADING ACETYLHYDROLASE, Biochimica et biophysica acta, L. Lipids and lipid metabolism, 1299(3), 1996, pp. 353-357
Authors:
TSELEPIS AD
DENTAN C
KARABINA SAP
CHAPMAN MJ
NINIO E
Citation: Ad. Tselepis et al., PAF-DEGRADING ACETYLHYDROLASE IS PREFERENTIALLY ASSOCIATED WITH DENSELDL AND VHDL-1 IN HUMAN PLASMA - CATALYTIC CHARACTERISTICS AND RELATION TO THE MONOCYTE-DERIVED ENZYME, Arteriosclerosis, thrombosis, and vascular biology, 15(10), 1995, pp. 1764-1773
Authors:
GOUDEVENOS J
TSELEPIS AD
TSOUKATOS D
GREKAS G
KRITIKAKOS J
SIDERIS D
Citation: J. Goudevenos et al., PLATELET AGGREGABILITY TO PLATELET-ACTIVATING-FACTOR AT REST AND AFTER EXERCISE IN PATIENTS WITH CORONARY-ARTERY DISEASE, European heart journal, 16(8), 1995, pp. 1036-1043
Authors:
KARABINA SAP
LIAPIKOS TA
GREKAS G
GOUDEVENOS J
TSELEPIS AD
Citation: Sap. Karabina et al., DISTRIBUTION OF PAF-ACETYLHYDROLASE ACTIVITY IN HUMAN PLASMA LOW-DENSITY-LIPOPROTEIN SUBFRACTIONS, Biochimica et biophysica acta, L. Lipids and lipid metabolism, 1213(1), 1994, pp. 34-38
Authors:
LIAPIKOS TA
ANTONOPOULOU S
KARABINA SAP
TSOUKATOS DC
DEMOPOULOS CA
TSELEPIS AD
Citation: Ta. Liapikos et al., PLATELET-ACTIVATING-FACTOR FORMATION DURING OXIDATIVE MODIFICATION OFLOW-DENSITY-LIPOPROTEIN WHEN PAF-ACETYLHYDROLASE HAS BEEN INACTIVATED, Biochimica et biophysica acta, L. Lipids and lipid metabolism, 1212(3), 1994, pp. 353-360
Authors:
TSOUKATOS D
DEMOPOULOS CA
TSELEPIS AD
MOSCHIDIS MC
DONOS A
EVANGELOU A
BENVENISTE J
Citation: D. Tsoukatos et al., INHIBITION BY CARDIOLIPINS OF PLATELET-ACTIVATING FACTOR-INDUCED RABBIT PLATELET ACTIVATION, Lipids, 28(12), 1993, pp. 1119-1124
Citation: Dc. Tsoukatos et al., STUDIES ON THE SUBCELLULAR-DISTRIBUTION OF 1-O-ALKYL-2-ACETYL-SN-GLYCERO PHOSPHOCHOLINE (PAF) AND ON THE ENZYMATIC-ACTIVITIES INVOLVED IN ITS BIOSYNTHESIS WITHIN THE CILIATE TETRAHYMENA-PYRIFORMIS, Biochimica et biophysica acta, 1170(3), 1993, pp. 258-264